Skip to main content
BKYI logo

BKYI · Bio Key International Inc · Investor Relations

Track BKYI — free
$2.10 -0.02 (-1.17%) Play latest call Q3 2026 earnings call transcript
Market Cap
$4.31M
Shares
2.04M
Volume · Nov 16 10.06K Avg daily vol (3M) 5.36M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-13 BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET
2026-08-14 Press Release, dated August 13, 2026, issued by the Company
2026-07-07 BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading resumes on Wednesday, July 8th
2026-06-10 BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing
2026-05-18 BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET
2026-05-12 BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today’s Market Close; BIO-key is Seeking to Restore
2026-04-29 Following Stockholder Approval, BIO-key Announces 1-for-10 Reverse Stock Split
2026-04-22 BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing
2026-04-20 BIO-key Expects 50% Increase in First Half Revenues, Driving Profitability in the Period
2026-03-31 BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET
2026-03-04 Retail Bank Executes Expanded $1.04M License Renewal for BIO-key Biometric Identity Solution Serving 30M Clients
2025-11-14 Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results; Highlights Enhanced Post Quarter Balance Sheet to Support 2026 Growth Goals; Holds Investor Call 10am ET Today

Past events

Date Event Type
2026-11-13 Q3 Earnings conference call (announced in 8-K) Earnings call
2026-08-14 Earnings conference call (announced in 8-K) Earnings call
2026-05-18 Earnings conference call (announced in 8-K) Earnings call
2026-03-31 Q4 Earnings conference call (announced in 8-K) Earnings call

Source: https://www.bio-key.com/investor-relations/

Key facts CIK 1019034 CUSIP 09060C606 13F (30d) 6 filings 6 filers Visit website Investor relations